Finance

Lists
Q2 2027 earnings • in 2 days
See details
MCHP:NASDAQ
Microchip Technology Inc
$76.11
-1.59%
(-1.23) 1D
$76.31
+0.26% (+0.20)
Pre-market
Closed: Nov 2, 4:00:02 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MCHP...
Open
$79.24
High
$80.51
Low
$75.90
Mkt. cap
41.33B
Avg. vol.
9.72M
Volume
5.87K
Dividend
2.39%
Quarterly dividend
$0.46
Ex-dividend date
Aug 24, 2026
P/E ratio
113.27
52-wk high
$105.91
52-wk low
$48.52
EPS
$0.67
Beta
1.77
Shares outstanding
543.01M
No. of employees
18K
Open
$79.24
High
$80.51
Low
$75.90
Mkt. cap
41.33B
Avg. vol.
9.72M
Volume
5.87K
Dividend
2.39%
Quarterly dividend
$0.46
Ex-dividend date
Aug 24, 2026
P/E ratio
113.27
52-wk high
$105.91
52-wk low
$48.52
EPS
$0.67
Beta
1.77
Shares outstanding
543.01M
No. of employees
18K
News stories
From web sources and news partners
Profile
Microchip Technology Incorporated is an American publicly traded semiconductor corporation that manufactures microcontrollers, microprocessors, integrated circuits, and flash memory. Its corporate headquarters is located in Chandler, Arizona. Its wafer fabs are located in Gresham, Oregon, and Colorado Springs, Colorado. The company's assembly/test facilities are in Chachoengsao, Thailand, and Calamba and Cabuyao, Philippines. Wikipedia
About Microchip Technology Inc
CEOSteve Sanghi
Employees17.9K
Founded1989
HeadquartersChandler, Arizona, United States
SectorSemiconductor
Websitemicrochip.com
Analyst ratings
Based on 17 analysts giving stock ratings to MCHP in the past 3 months
Buy
Buy
12
Hold
5
Sell
0
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for MCHP in the last 3 months.
Highest
Current $76.11
$135.00 (+77.37%)
Average
$105.65 (+38.81%)
Lowest
$80.00 (+5.11%)
Analyst
Recommendation
Action
Price target
Projected
Date
Craig Ellis
B. Riley Securities
Buy
Maintained
$98.00
+28.8%
10/22/2026
Joseph Quatrochi
Wells Fargo
Hold
Reiterated
$80.00
+5.1%
10/20/2026
John Vinh
KeyBanc
Buy
Maintained
$135.00
+77.4%
10/15/2026
Joseph Moore
Morgan Stanley
Hold
Reiterated
$103.00
+35.3%
09/18/2026
Harsh Kumar
BMO Capital
Buy
Initiated
$95.00
+24.8%
08/20/2026
Unknown Analyst
BMO Capital
Buy
Initiated
$95.00
+24.8%
08/20/2026
William Stein
Truist Financial
Hold
Maintained
$90.00
+18.2%
08/11/2026
Atif Malik
Citi
Buy
Maintained
$95.00
+24.8%
08/10/2026
Kevin Cassidy
Rosenblatt Securities
Buy
Maintained
$120.00
+57.7%
08/07/2026
Christopher Rolland
Susquehanna
Buy
Reiterated
$120.00
+57.7%
08/07/2026
Vivek Arya
Bank of America Securities
Buy
Reiterated
$100.00
+31.4%
08/07/2026
Tore Svanberg
Stifel Nicolaus
Buy
Maintained
$108.00
+41.9%
08/07/2026
Quinn Bolton
Needham
Buy
Maintained
$120.00
+57.7%
08/07/2026
Timothy Arcuri
UBS
Buy
Reiterated
$120.00
+57.7%
08/07/2026
Thomas O'Malley
Barclays
Hold
Maintained
$105.00
+38%
08/07/2026
Joshua Buchalter
TD Cowen
Hold
Maintained
$90.00
+18.2%
08/06/2026
Blayne Curtis
Jefferies
Buy
Reiterated
$100.00
+31.4%
08/07/2026
Mark Lipacis
Evercore ISI
Buy
Maintained
$117.00
+53.7%
08/07/2026
Matthew Prisco
Cantor Fitzgerald
Buy
Maintained
$125.00
+64.2%
08/03/2026
Vijay Rakesh
Mizuho Securities
Buy
Maintained
$112.00
+47.2%
06/28/2026
Unknown Analyst
Wells Fargo
Hold
Reiterated
$95.00
+24.8%
06/09/2026
James Schneider
Goldman Sachs
Buy
Maintained
$115.00
+51.1%
05/08/2026
Melissa Fairbanks
Raymond James
Buy
Maintained
$125.00
+64.2%
05/08/2026
Harlan Sur
J.P. Morgan
Buy
Reiterated
$120.00
+57.7%
05/08/2026
C J Muse
Cantor Fitzgerald
Buy
Reiterated
$100.00
+31.4%
05/04/2026
Next call in 2 days
Thu, Nov 5, 5:00 PM
Fiscal period
Q2 2027
- / $0.94
Revenue / Est. (USD)
- / 1.61B
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.14B
1.19B
1.31B
1.48B
Cost of goods sold
502.50M
479.10M
511.60M
545.80M
Cost of revenue
502.50M
479.10M
511.60M
545.80M
Research and development expenses
262.30M
274.30M
293.80M
308.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
172.30M
168.50M
174.20M
184.30M
Operating expense
542.70M
550.40M
575.80M
583.20M
Total operating expenses
1.05B
1.03B
1.09B
1.13B
Operating income
95.20M
156.50M
223.80M
355.70M
Other non operating income
-4.40M
-3.50M
-3.40M
-
EBT including unusual items
31.80M
93.60M
163.90M
289.90M
EBT excluding unusual items
38.10M
98.40M
170.30M
308.80M
Income tax expense
-9.90M
30.90M
19.70M
60.10M
Effective tax rate
-31.13%
33.01%
12.02%
20.73%
Other operating expenses
-
-
-
-
Net income
41.70M
62.70M
144.20M
229.80M
Net profit margin
3.66%
5.29%
11.00%
15.48%
Earnings per share
0.35
0.44
0.57
0.76
Interest and investment income
3.60M
1.30M
1.60M
1.40M
Interest expense
-56.30M
-55.90M
-51.70M
-48.80M
Net interest expenses
-52.70M
-54.60M
-50.10M
-47.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
267.90M
328.30M
397.50M
512.40M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps